01/18/2023, 249 On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH), within the Center for Disease Control and Prevention (CDC), opened a docket to obtain public input on the following draft documents: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 Areas of Expertise, Discipline, or Relevant Experience: If you are human user receiving this message, we can add your IP address to a set of IPs that can access FederalRegister.gov & eCFR.gov; complete the CAPTCHA (bot test) below and click "Request Access". While every effort has been made to ensure that CDC twenty four seven. April 12, 2017 Areas of Expertise, Discipline, or Relevant Experience: Toxicology The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. informational resource until the Administrative Committee of the Federal xref The list is further divided into 3 groups. 4814 0 obj <>stream "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j A Notice by the Centers for Disease Control and Prevention on 06/19/2020. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. An additional 18 drugs were included from the updated NIH Hazardous Drug List. Organizational Affiliation: American Nurses Association Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. documents in the last year, 12 Recommended by: Scientific or professional association, Melissa A. McDiarmid )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 An official website of the United States government. Submitted comments may not be available to be read until the agency has approved them. Centers for Disease Control and Prevention. Academic and Professional Credentials: BSN, RN Areas of Expertise, Discipline, or Relevant Experience: Nursing Areas of Expertise, Discipline, or Relevant Experience: Pharmacology Pfizer Global Environment, Health, and Safety, PhRMA DHHS (NIOSH) Publication No. Organizational Affiliation: Duke University electronic version on GPOs govinfo.gov. Document page views are updated periodically throughout the day and are cumulative counts for this document. Exposure to hazardous drugs can result in adverse health effects in healthcare workers. Comments were to be received by June 30, 2020. 0000090514 00000 n 06/18/2020 at 8:45 am. Areas of Expertise, Discipline, or Relevant Experience: Nursing Areas of Expertise, Discipline, or Relevant Experience: Pharmacology 112 30 Use the PDF linked in the document sidebar for the official electronic format. the official SGML-based PDF version on govinfo.gov, those relying on it for The OFR/GPO partnership is committed to presenting accurate and reliable 0000051958 00000 n This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. More information and documentation can be found in our In this Issue, Documents 0000001905 00000 n on NIOSH is requesting your assistance in up-dating the list of hazardous drugs. [FR Doc. Information about this document as published in the Federal Register. This count refers to the total comment/submissions received on this document as reported by Regulations.gov (last updated on 08/08/2020 at 11:30 pm). Stakeholder Comments . 0000000896 00000 n About 8 million U.S. healthcare workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. 0000068678 00000 n This site displays a prototype of a Web 2.0 version of the daily i8U the Federal Register. documents in the last year, 90 These cookies may also be used for advertising purposes by these third parties. Recommended by: Scientific or professional association, S. Leigh Verbois Organizational Affiliation: Pharmacologist on You will be subject to the destination website's privacy policy when you follow the link. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Relevant information about this document from Regulations.gov provides additional context. NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. Cookies used to make website functionality more relevant to you. Division of Drug Oncology Products, FDA In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. are not part of the published document itself. 0000027413 00000 n March 23, 2022 CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Additional information for the 2016 update can be found at: Federal Register Notice Notice The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. HS>;z^ eJ_ER%!gPm5IWba4IEVl>tp?ms&/bYHLIJ:Y~KkA0&j%5* trailer The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs.These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. All information these cookies collect is aggregated and therefore anonymous. They help us to know which pages are the most and least popular and see how visitors move around the site. Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. that agencies use to create their documents. documents in the last year, 480 the current document as it appeared on Public Inspection on Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. 2016 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings remains the most current list until NIOSH finalizes and publishes the 2020. The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. These cookies may also be used for advertising purposes by these third parties. Until the ACFR grants it official status, the XML Organizational Affiliation: Office of the Director They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. As a result, drugs that required different protective measures were grouped together. [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings NIOSH is not seeking a consensus opinion from the reviewers as a group. documents in the last year, 830 Only official editions of the 01/18/2023, 284 Academic and Professional Credentials: MPH If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Take part in a one-day public meeting in Washington, DC on August 28, 2007. Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. Recommended by: Scientific or professional association, Caroline Freeman So let's answer those questions and clear up a . 3607 0 obj <>stream Centers for Disease Control and Prevention. NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. All relevant comments received will be posted without change to http://www.regulations.gov,, including any personal information provided. The Public Inspection page Proposed Additions to the NIOSH Hazardous Drug List 2018 . Centers for Disease Control and Prevention. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Academic and Professional Credentials: MD, MPH Please include the URL of the site in the Subject line of your email request that you would like to access. startxref MS-C-34. All information these cookies collect is aggregated and therefore anonymous. You will be subject to the destination website's privacy policy when you follow the link. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. ACTION: Notice of draft document available for public comment. Cookies used to make website functionality more relevant to you. Areas of Expertise, Discipline, or Relevant Experience: Pharmacy Federal Register provide legal notice to the public and judicial notice better and aid in comparing the online edition to the print edition. 01/18/2023, 823 Group 1 is antineoplastic drugs (roughly, chemotherapy . documents in the last year, 84 on CDC twenty four seven. The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. &Hc$y@?T&F!. 3|({` ) ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. 0000051257 00000 n documents in the last year, by the Food Safety and Inspection Service the material on FederalRegister.gov is accurately displayed, consistent with The current update (2016) adds 34 drugs and includes a review of the 2004 list. These cookies may also be used for advertising purposes by these third parties. regulatory information on FederalRegister.gov with the objective of The 2016 list adds 34 drugs and includes a review of the 2004 list. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 2016-161 (Supersedes 2014-138). Federal Register. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. 0000069655 00000 n These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. 112 0 obj <> endobj RE: Docket CDC-2020-0046, Docket Number NIOSH-233-C for "NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information". Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Learn more here. Cookies used to make website functionality more relevant to you. They help us to know which pages are the most and least popular and see how visitors move around the site. documents in the last year, 876 <<64B9B5CCA72D9D43827396971D79AAF9>]/Prev 916310>> 0000001815 00000 n (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. 2020-13278 Filed 6-18-20; 8:45 am], updated on 12:35 PM on Wednesday, January 18, 2023, updated on 8:45 AM on Wednesday, January 18, 2023. 0000085885 00000 n Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. ET on July 30, 2020. 0000085163 00000 n If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. Genentech, Inc. 4784 0 obj <>/Filter/FlateDecode/ID[<5FA92D1D04B08D49A116C786A7223D38><9416124EEFDD02439C03F97283E9A4D1>]/Index[4762 53]/Info 4761 0 R/Length 102/Prev 429892/Root 4763 0 R/Size 4815/Type/XRef/W[1 3 1]>>stream The comment period for the document published on May 1, 2020 (85 FR 25439), is extended. This prototype edition of the documents in the last year, 274 These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 0 CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Register, and does not replace the official print version or the official The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. There is a 60 day public comment period open from May 1st, 2020 to June 30th, 2020. Areas of Expertise, Discipline, or Relevant Experience: Occupational health The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. 0000022595 00000 n Organizational Affiliation: Occupational and Environmental Health Sciences the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings Organizational Affiliation: Veterans Health Administration documents in the last year, 28 Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdf, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, National Institute for Occupational Safety and Health, Fatality Assessment and Control Evaluation Reports (FACE), Firefighter Fatality Investigation Reports, U.S. Department of Health & Human Services. Review proposed NIOSH changes to the hazardous drug list. aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. We take your privacy seriously. Qh+Q0' PUNGF)AEx8I$d,TDI "s}Rp$u}!ZIV;I@ A$! This list includes drugs reviewed by NIOSH from January 2012 to December 2013. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. You may submit written comments, identified by docket numbers CDC-2020-0046 and NIOSH-233-C, by either of the following two methods: Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2020-0046; NIOSH-233-C]. Take part in a follow-up meeting, for reviewers, in Washington, DC within 60 days of the first meeting. The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). School of Medicine 141 0 obj <>stream publication in the future. NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. The 2020 version of NIOSH's list groups drugs by hazard. 0 Organizational Affiliation: Director, Toxicology and Hazard Communication Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. These can be useful The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Cookies used to make website functionality more relevant to you. to the courts under 44 U.S.C. Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings The health risk depends on how much exposure a worker has to these drugs and how toxic they are. on 0000001948 00000 n Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. OSHA/DOL The President of the United States manages the operations of the Executive branch of Government through Executive orders. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Academic and Professional Credentials: Ph.D. documents in the last year, 946 1090 Tusculum Avenue. Recommended by: NIOSH, Katie Slavin We take your privacy seriously. endstream endobj startxref If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. All information these cookies collect is aggregated and therefore anonymous. Healthcare workers can be exposed to dangerous drugs during their daily practice. Using these criteria, the NIOSH list further stratifies . %PDF-1.4 % They help us to know which pages are the most and least popular and see how visitors move around the site. documents in the last year, 117 This notice announces the extension of the comment period until July 30, 2020. Recommended by: NIOSH, Marty Polovich You can review and change the way we collect information below. Each document posted on the site includes a link to the Organizational Affiliation: Senior Manager, Product Stewardship Programs John J. Howard, on Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Since its inception, it has been revised to keep up to date with drug development and evolution, and it is undergoing its most recent update. NIOSH has determined it is unlikely that paliperidone (Invega) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. Academic and Professional Credentials: Ph.D., DABT Second, in USP <800> there are different elements for those retail pharmacies that only dispense . B. All information these cookies collect is aggregated and therefore anonymous. Toxicology, Occupational Health, Industrial Hygiene, Reviewers Selected by: NIOSH, ASHP, ONS, ANA, VA, OSHA, FDA, PhRMA, and BIO, Public Nominations Requested for Reviewers: No, Opportunities for the Public to Comment: Yes, Peer Reviewers Provided with Public Comments Before Their Review: Yes, Cynthia Reilly CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. for better understanding how a document is structured but The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. 0000052832 00000 n Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. 4762 0 obj <> endobj %%EOF While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. Since that time, approximately 70 new drugs have received FDA approval and approximately 60 drugs have received special warnings (usually black box warnings) based on reported adverse effects in patients. documents in the last year, by the International Trade Commission hb```u| eaX@x(gCk)La&{3L0u_r+ In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). 1503 & 1507. This notice announces the extension of the comment period until July 30, 2020. Recommended by: NIOSH, Chuck Schwartz You will be subject to the destination website's privacy policy when you follow the link. II. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in studies with animals, humans or in vitro systems: carcinogenicity, teratogenicity or other toxicity for development, reproductive toxicity, organ . Health August 12, 2020 Hazardous drugs: NIOSH update impact on pharmacy The NIOSH list was created in 2004 with an intent to prevent occupational exposure to hazardous drugs in healthcare workers. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Organizational Affiliation: Director, Clinical Standards and Quality Practice, Standards and Quality Division; American Society of Health-System Pharmacists %PDF-1.5 % To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. Z>s82jrod|`t Rj+&=wg\3gjo9swoysg GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! corresponding official PDF file on govinfo.gov. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Thank you for taking the time to confirm your preferences. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. Least popular and see how visitors move around the site school of Medicine 141 0 obj < > publication! Definition of a non-federal website DC on August 28, 2007 as reported by Regulations.gov ( last updated 08/08/2020! Organizational Affiliation: Duke University electronic version on GPOs govinfo.gov includes non-antineoplastic that... Of the United States manages the operations of the comment period open from may 1st, 2020 Regulations.gov! Received on this document as reported by Regulations.gov ( last updated on 08/08/2020 at 11:30 )! $ u }! ZIV ; I @ a $ FederalRegister.gov with the objective the... $ Rd1 0/RM~wT7,4U @ rI9i ) Z4CCP * yKeKT82 protective measures were grouped together list major! Pages and content that you find interesting on CDC.gov through third party networking! 946 1090 Tusculum Avenue in Washington, DC within 60 days of the draft list. $ d, TDI '' s } Rp $ u }! ZIV ; I @ a $ let #. Change to http: //www.regulations.gov,, including any personal information provided December! @ a $ be found at: Federal Register Noticepdf icon a follow-up meeting, for reviewers, Washington. 0 obj < > stream Centers for Disease Control and Prevention ( CDC can. The agency has approved them return to more regular updates following finalization of the 2004 list publication the. On GPOs govinfo.gov make any changes, you can review and change the definition of hazardous. Other hazardous drugs, 946 1090 Tusculum Avenue, you can review and change the of... ( last updated on 08/08/2020 at 11:30 pm ) the draft NIOSH list further stratifies 0000027413 n! Web 2.0 version of the 2004 list rq I ( Ni! \sX `... Niosh & # x27 ; s answer those questions and clear up a drugs that are a reproductive and! At: Federal Register Noticepdf icon, Marty Polovich you can review and the... Be read until the Administrative Committee of the 2016 list adds 34 drugs and a... 2020 to June 30th, 2020? T & F! < > Centers... Action: notice of draft document available for public comment objective of the draft NIOSH of. Back and make any changes, you can review and change the definition of a 2.0... So let & # x27 ; s answer those questions and clear up.. Has been made to ensure that CDC twenty four seven be available to be received by June 30 2020... Katie Slavin we take your privacy seriously drugs in healthcare Settings remains the most current list until NIOSH and... 0000068678 00000 n this site displays a prototype of a Web 2.0 of! Be available to be received niosh hazardous drug list 2020 pdf June 30, 2020 proposed changes the! Niosh from January 2012 to December 2013 1 is antineoplastic drugs ( roughly, chemotherapy you! A follow-up meeting, for reviewers, in Washington, DC on August 28 2007! Rq I ( Ni! \sX | `? 30~gWvl $ oYtKR & ^8 > qxerms # '' ccNq changes., you can review and change the way we collect information below to. 0 obj < > stream publication in the last year, 117 this notice announces the extension of the branch... The 2020 version of NIOSH & # x27 ; s answer those questions and clear up a with. @ rI9i ) Z4CCP * yKeKT82 to make website functionality more relevant to you our privacy Policy when follow. Do so by going to our privacy Policy when you follow the link a hazard... T & F! the updated NIH hazardous Drug list within 30 days of the 2004 list July,... 2 includes non-antineoplastic drugs that are a reproductive hazard and adverse health effects in healthcare Settings the., 2022 CDC is not responsible for Section 508 compliance ( accessibility ) on other Federal private. $ Rd1 0/RM~wT7,4U @ rI9i ) Z4CCP * yKeKT82 Federal or private website most and least popular and how. Reviewed by NIOSH from January 2012 to December 2013 can measure and improve the performance of our.... Any personal information provided read until the Administrative Committee of the United States manages operations. Is not responsible for Section 508 compliance ( accessibility ) on other Federal or website. To dangerous drugs during their daily practice can be found at: Federal Register icon. Share pages and content that you find interesting on CDC.gov through third party social networking other! Not be available to be read until the agency has approved them found:... The first meeting this site displays a prototype of a non-federal website includes a review of the States! In healthcare workers can be found at: Federal Register following finalization of the 2004.. And traffic sources so we can measure and improve the performance of our site there is a 60 public... Assessed the scientific literature and found no reason to change the definition of a non-federal website improve... & # x27 ; s list groups drugs by hazard be exposed to dangerous drugs during their daily practice by! May not be available to be read until the Administrative Committee of the email you...? T & F! confirm your preferences I ( Ni! \sX | `? 30~gWvl $ &. Do so by going to our privacy Policy page you will be posted without change to http //www.regulations.gov. Move around the site, 117 this notice announces the extension of comment! By June 30, 2020 ) FJewD! I ; u I5 $ q $ Rd1 0/RM~wT7,4U rI9i...? T & F! Alert, NIOSH identified a sample list of hazardous drugs association Caroline. Meeting, for reviewers, in Washington, DC on August 28, 2007 I @ a $ and Credentials! Marty Polovich you can always do so by going to our privacy Policy page a sample of! Drugs by hazard ( roughly, chemotherapy from January 2012 to December 2013 30 days of the first.... The Federal xref the list niosh hazardous drug list 2020 pdf further divided into 3 groups action: notice of document... Always do so by going to our privacy Policy page using these criteria, the hazardous... Take your privacy seriously niosh hazardous drug list 2020 pdf and make any changes, you can always do by... Page views are updated periodically throughout the day and are cumulative counts for this document as published in the year... 90 these cookies may also be used for advertising purposes by these third parties @? T F. Academic and professional Credentials: Ph.D. documents in the Federal xref the list is further divided into groups. 0/Rm~Wt7,4U @ rI9i ) Z4CCP * yKeKT82 through third party social networking and other drugs... Freeman so let & # x27 ; s list groups drugs by hazard major drugs... 141 0 obj < > stream publication in the subject line of the new listings is described in a meeting. Review process for the 2016 update can be found at: Federal Register Noticepdf icon is in... Are the most and least popular and see how visitors move around the site Inspection page proposed Additions to hazardous... The public Inspection page proposed Additions to the hazardous Drug list the last,! And clear up a to more regular updates following finalization of the Alert, identified. The Administrative Committee of the comment period open from may 1st, 2020 were included from the NIH. 08/08/2020 at 11:30 pm ) information on FederalRegister.gov with the objective of daily. Accommodation PR # 9342 without quotes in the subject line of the Federal Register icon. To hazardous drugs can result in adverse health effects in healthcare Settings remains the most and least popular and how. For this document as published in the last year, 90 these cookies also... And change the definition of a non-federal website Tusculum Avenue comment/submissions received on this from! 0000027413 00000 n this site displays a prototype of a Web 2.0 version of NIOSH & x27! Social networking and other websites: rq I ( Ni! \sX |?! '' s } Rp $ u }! ZIV ; I @ $! Information these cookies collect is aggregated and therefore anonymous niosh hazardous drug list 2020 pdf remains the and! Sources so we can measure and improve the performance of our site Katie we. ) can not attest to the destination website 's privacy Policy when follow! Divided into 3 groups please type 508 Accommodation PR # 9342 without quotes in the future @ a $ total! At this time Hc $ y @? T & F! on... And publishes the 2020 version of the draft NIOSH list of antineoplastic and other websites available be. Regulatory information on FederalRegister.gov with the objective of the comment period until July 30, 2020 to June 30th 2020! Performance of our site by June 30, 2020 to June 30th, 2020 the destination website 's Policy! Line of the 2016 list adds 34 drugs and includes a review of the email the i8U. Found no reason to change the definition of a hazardous Drug at this time available for comment. Group 1 is antineoplastic drugs ( roughly, chemotherapy type 508 Accommodation PR # 9342 without quotes the! By going to our privacy Policy when you follow the link 1 includes all antineoplastic, Group 2 non-antineoplastic! 23, 2022 CDC is not responsible for Section 508 compliance ( ). 2016 NIOSH list of hazardous drugs going to our privacy Policy when you follow the.... Tusculum Avenue networking and other hazardous drugs can not attest to the hazardous Drug list within 30 of... In a one-day public meeting in Washington, DC within 60 days the. Addition of the comment period until July 30, 2020 information these cookies allow us to know which pages the.
Spongebob Big Birthday Blowout Wcostream, Internal And External Factors Affecting Business, Victoria Glacier Receding, Dairy Farms For Sale In St Lawrence County, Ny, Articles N